Abstract:MicroRNAs have emerged as key regulators of both normal and pathologic phenotypes, including cancer. Fine grain regulation of their biogenesis, however, is still a poorly understood process and only a relatively small repertoire of proteins controlling its key steps has been characterized. In order to understand the extent and specificity of microRNA biogenesis control, as well as its role in glioblastoma tumorigenesis and progression, we developed and experimentally validated miRage, an algorithm for genome-wide inference of microRNA biogenesis regulators. MiRage identifies biogenesis-regulator candidates using the conditional mutual information between the candidates, mature microRNAs precursors, and abundance to identify those proteins that are required for the maturation of microRNAs. miRage predicted hundreds of potential biogenesis regulators that are either specific to individual microRNAs or to microRNA families. Several of the inferred regulators that are differentially expressed across glioblastoma prognosis were validated in the SNB19 cell line. Differential expression of mature microRNAs, their host genes, and their precursors were measured before and after ectopic expression or RNAi mediated silencing of predicted regulators. ACSM3, which is predicted to regulate 70% of the differentially expressed microRNAs in glioblastoma, was shown to post-transcriptionally inhibit miR-155. This microRNA is an experimentally validated regulator of CEBPβ, a master regulator of the mesenchymal signature of GBM; indeed siRNA-mediated silencing of ACSM3 dramatically activated miR-155 and down-regulated CEBPβ. In addition, several members of the DDX RNA-binding protein family were inferred as specific regulators of microRNA biogenesis. For instance, we show that DDX10 activates miR-218 and inhibits miR-9; up regulation of DDX10 may account for miR-218 overexpression in poor-prognosis tumors. We showed that RBBP4 inhibits miR-23b, WDR8 inhibits miR-18b, ACTA2 inhibits miR-218, and PRIC285 inhibits miR-196a and miR-25. Taken together, these results suggest that microRNA biogenesis is a much more complex and finely regulated process than previously thought, and that microRNA biogenesis regulators may play a key role in tumor initiation and progression. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr LB-337. doi:10.1158/1538-7445.AM2011-LB-337

Reduced Expression of hsa-miR-338-3p Contributes to the Development of Glioma Cells by Targeting Mitochondrial 3-Oxoacyl-ACP Synthase (OXSM) in Glioblastoma (GBM)

SPI1-induced Downregulation of FTO Promotes GBM Progression by Regulating Pri-Mir-10a Processing in an M6a-Dependent Manner

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

The Mir-92B Functions As a Potential Oncogene by Targeting on Smad3 in Glioblastomas

Long Non-Coding RNA HOTAIRM1 Promotes Proliferation and Inhibits Apoptosis of Glioma Cells by Regulating the Mir-873-5p/zeb2 Axis

MiR-302c-3p Suppresses Invasion and Proliferation of Glioma Cells Via Down-Regulating Metadherin (MTDH) Expression.

MicroRNA-509-3p Inhibits Cell Proliferation and Invasion Via Downregulation of X-linked Inhibitor of Apoptosis in Glioma.

Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1

Hypoxia-Induced miR-137 Inhibition Increased Glioblastoma Multiforme Growth and Chemoresistance Through LRP6

miR-139/PDE2A-Notch1 feedback circuit represses stemness of gliomas by inhibiting Wnt/β-catenin signaling

SCIDOT-27. TGFβ SIGNALING-INDUCED Mirna PARTICIPATES IN AUTOPHAGIC REGULATION BY TARGETING PRAS40 IN MESENCHYMAL SUBTYPE OF GLIOBLASTOMA

Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1

Mir-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells

miR-29a-5p Regulates the Proliferation, Invasion, and Migration of Gliomas by Targeting DHRS4

In Silico Analysis Identified Mirna-Based Therapeutic Agents Against Glioblastoma Multiforme

MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1

Abstract LB-337: Post-transcriptional regulators of microRNA biogenesis drive glioblastoma-specific expression

MicroRNA-377 Inhibited Proliferation and Invasion of Human Glioblastoma Cells by Directly Targeting Specificity Protein 1.

TGF signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma

miRNA-338-3p inhibits glioma cell proliferation and progression by targeting MYT1L

Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses